Form 4 for GNPX Genprex, Inc.
Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-18 · accession 0001437749-24-005058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-21 | 2024-02-18 | GNPX | Varner John Rodney | COB, Pres, CEO, Dir | F - Tax | $4.40 | -2,642 | 26.4K | -9% | -$11.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-18 | F | D | 2,642 | $4.40 | 26,352 | D | — | — | (F1) Represents shares withheld on February 18, 2024 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan. (F2) This total represents the number of shares of Common Stock directly beneficially owned following this reported transaction and the 1-for-40 reverse stock split of the Company's Common Stock effected as of February 2, 2024 (the "RSS"). |